Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Sep;9(9):3487-3489.
doi: 10.1016/j.jaip.2021.06.032. Epub 2021 Jul 2.

Safety of BNT162b2 mRNA COVID-19 vaccine in patients with mast cell disorders

Yossi Rosman  1 , Noa Lavi  2 , Keren Meir-Shafrir  3 , Idit Lachover-Roth  4 , Anat Cohen-Engler  4 , Yoseph A Mekori  4 , Ronit Confino-Cohen  4
Affiliations

Safety of BNT162b2 mRNA COVID-19 vaccine in patients with mast cell disorders

Yossi Rosman et al. J Allergy Clin Immunol Pract. 2021 Sep.
No abstract available

PubMed Disclaimer

References

    1. Theoharides T.C., Valent P., Akin C. Mast cells, mastocytosis, and related disorders. N Engl J Med. 2015;373:163–172. - PubMed
    1. Zanoni G., Zanotti R., Schena D., Sabbadini C., Opri R., Bonadonna P. Vaccination management in children and adults with mastocytosis. Clin Exp Allergy. 2017;47:593–596. - PubMed
    1. Shimabukuro T.T., Cole M., Su J.R. Reports of anaphylaxis after receipt of mRNA COVID-19 vaccines in the US–December 14, 2020-January 18, 2021. JAMA. 2021;325:1101–1102. - PMC - PubMed
    1. Castells M.C., Phillips E.J. Maintaining safety with SARS-CoV-2 vaccines. N Engl J Med. 2021;384:643–649. - PMC - PubMed
    1. Azenha Rama T., Álvarez-Twose I. Delving into COVID-19 vaccination-induced anaphylaxis: are mRNA vaccines safe in mast cell disorders? J Investig Allergol Clin Immunol. 2021;31:193–195. - PubMed